Philip Conzentino, Jr

Title: The Innovations of Philip Conzentino, Jr.

Introduction

Philip Conzentino, Jr. is an accomplished inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on nanoparticles. His research focuses on enhancing the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) while minimizing side effects.

Latest Patents

Conzentino holds a patent for "Surface modified NSAID nanoparticles." This invention involves dispersible particles that consist essentially of a crystalline NSAID with a surface modifier adsorbed on its surface. The amount of surface modifier is sufficient to maintain an effective average particle size of less than about 400 nm. Pharmaceutical compositions containing these particles exhibit reduced gastric irritation following oral administration and/or hastened onset of action. He has 1 patent to his name.

Career Highlights

Conzentino's career is marked by his dedication to advancing pharmaceutical technology. His work has the potential to improve patient outcomes by reducing the side effects commonly associated with NSAIDs. He is associated with Nanosystems LLC, where he continues to innovate and develop new solutions in the pharmaceutical industry.

Collaborations

Throughout his career, Conzentino has collaborated with notable professionals in his field, including Gary G. Liversidge and Kenneth C. Cundy. These collaborations have further enriched his research and contributed to the development of effective pharmaceutical solutions.

Conclusion

Philip Conzentino, Jr. is a notable inventor whose work on NSAID nanoparticles demonstrates his commitment to improving pharmaceutical formulations. His innovations have the potential to significantly enhance patient care and treatment efficacy.